Editas Medicine, Inc.
EDIT· Nasdaq
Editas Medicine, Inc.
- Last sale
- Oct 2, 2026 · +3.77%
- Market cap
- $401.61M
- 153.58M shares
- Filings
- 725
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $40,520,000 | reported | |
| FY 2024 | 2024-12-31 | $32,314,000 | reported | |
| FY 2023 | 2023-12-31 | $78,123,000 | reported | |
| FY 2022 | 2022-12-31 | $19,712,000 | reported | |
| FY 2021 | 2021-12-31 | $25,544,000 | reported | |
| FY 2020 | 2020-12-31 | $90,732,000 | reported | |
| FY 2019 | 2019-12-31 | $20,531,000 | reported | |
| FY 2018 | 2018-12-31 | $31,937,000 | reported | |
| FY 2017 | 2017-12-31 | $13,728,000 | reported | |
| FY 2016 | 2016-12-31 | $6,053,000 | reported |
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
